Skip to menu Skip to content Skip to footer
Dr Yee Weng Wong
Dr

Yee Weng Wong

Email: 

Overview

Background

Dr. Yee Weng Wong is a clinical cardiologist with sub-specialty interests in cardiomyopathy, heart failure, cardiac transplantation and adult mechanical circulatory support.

In addition to his clinical interest, Dr Wong is an early career clinician researcher, with focus on translational research in reducing the morbidity and mortality associated with heart failure and development of novel therapeutic targets. Dr Wong is also committed in bringing his clinical and quantitative perspective to healthcare system improvement and implementation science initiatives.

Availability

Dr Yee Weng Wong is:
Available for supervision
Media expert

Research interests

  • Clinical Trials

  • Health Service Research

  • Artificial Intelligence in Medicine

  • Registry

  • Heart Failure

  • Cardiac Transplantation

  • Mechanical Circulatory Support

Works

Search Professor Yee Weng Wong’s works on UQ eSpace

68 works between 2006 and 2024

1 - 20 of 68 works

2024

Conference Publication

Resting Left Atrial Reservoir Stain—A Single Parameter to Exclude HFpEF

Tomlinson, S., Savage, M., Edwards, N., McKenzie, S., Wong, Y., Dashwood, A., Chamberlain, R., Loy, J., Grisanti, C., Scalia, G. and Chan, W. (2024). Resting Left Atrial Reservoir Stain—A Single Parameter to Exclude HFpEF. 72nd Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Perth, WA Australia, 1-4 August 2024. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2024.06.186

Resting Left Atrial Reservoir Stain—A Single Parameter to Exclude HFpEF

2024

Conference Publication

Functional And Hematological Implications Of Distinct Definitions Of Iron Deficiency In Heart Failure: A Substudy From The HEART-FID Trial

Lewis, Gregory D., Giczewska, Anna, Mentz, Robert John, Butler, Javed, Ezekowitz, Justin A., O'Meara, Eileen, Troughton, Richard W., Ponikowski, Piotr, Wong, Yee Weng, Malhotra, Rajeev, Blackman, Nicole, Rockhold, Frank and Hernandez, Adrian F. (2024). Functional And Hematological Implications Of Distinct Definitions Of Iron Deficiency In Heart Failure: A Substudy From The HEART-FID Trial. ACC.24, Atlanta, GA United States, 6-8 April 2024. San Diego, CA United States: Elsevier. doi: 10.1016/s0735-1097(24)02372-6

Functional And Hematological Implications Of Distinct Definitions Of Iron Deficiency In Heart Failure: A Substudy From The HEART-FID Trial

2024

Journal Article

SERUM PHOSPHATE LEVELS OVER TIME WITH INTRAVENOUS FERRIC CARBOXYMALTOSE AS TREATMENT FOR HEART FAILURE WITH REDUCTION EJECTION FRACTION AND IRON DEFICIENCY: A PROSPECTIVE SUBSTUDY FROM HEART-FID

Nouhravesh, Nina, Garg, Jyotsna, Rockhold, Frank, De Pasquale, Carmine, O'Meara, Eileen, Lewis, Gregory D., Butler, Javed, Harrington, Josephine, Ezekowitz, Justin A., Ponikowski, Piotr, Troughton, Richard W., Wong, Yee Weng, Blackman, Nicole, Numan, Syed, Adamczyk, Robert, Hernandez, Adrian F. and Mentz, Robert John (2024). SERUM PHOSPHATE LEVELS OVER TIME WITH INTRAVENOUS FERRIC CARBOXYMALTOSE AS TREATMENT FOR HEART FAILURE WITH REDUCTION EJECTION FRACTION AND IRON DEFICIENCY: A PROSPECTIVE SUBSTUDY FROM HEART-FID. Journal of the American College of Cardiology, 83 (13), 383. doi: 10.1016/s0735-1097(24)02373-8

SERUM PHOSPHATE LEVELS OVER TIME WITH INTRAVENOUS FERRIC CARBOXYMALTOSE AS TREATMENT FOR HEART FAILURE WITH REDUCTION EJECTION FRACTION AND IRON DEFICIENCY: A PROSPECTIVE SUBSTUDY FROM HEART-FID

2024

Conference Publication

All-cause Mortality In The HEART-FID Trial

Ezekowitz, Justin A., Mulder, Hillary, Mentz, Robert John, Butler, Javed, De Pasquale, Carmine, Lewis, Gregory D., O'Meara, Eileen, Ponikowski, Piotr, Troughton, Richard W., Wong, Yee Weng, Blackman, Nicole, Numan, Syed, Rockhold, Frank and Hernandez, Adrian F. (2024). All-cause Mortality In The HEART-FID Trial. ACC.24, Atlanta, GA United States, 6-8 April 2024. San Diego, CA United States: Elsevier. doi: 10.1016/s0735-1097(24)02481-1

All-cause Mortality In The HEART-FID Trial

2024

Journal Article

Hierarchical end points in prior heart failure trials and the HEART-FID Trial

Harrington, Josephine, Mentz, Robert J., Rockhold, Frank W., Garg, Jyotsna, Butler, Javed, De Pasquale, Carmine G., Ezekowitz, Justin A., Lewis, Gregory D., O’Meara, Eileen, Ponikowski, Piotr, Troughton, Richard W., Wong, Yee W., Adamczyk, Robert, Storie, Tatyana, Blackman, Nicole and Hernandez, Adrian F. (2024). Hierarchical end points in prior heart failure trials and the HEART-FID Trial. Circulation: Heart Failure, 17 (2) e010676, 169-177. doi: 10.1161/circheartfailure.123.010676

Hierarchical end points in prior heart failure trials and the HEART-FID Trial

2024

Book Chapter

Roles of β-adrenoceptor subtypes and therapeutics in human cardiovascular disease: heart failure, tachyarrhythmias and other cardiovascular disorders

Wong, Yee Weng, Haqqani, Haris and Molenaar, Peter (2024). Roles of β-adrenoceptor subtypes and therapeutics in human cardiovascular disease: heart failure, tachyarrhythmias and other cardiovascular disorders. Adrenoceptors. (pp. 1-49) edited by Jillian G. Baker, Martin C. Michel and Roger J. Summers. Berlin, Heidelberg: Springer Berlin Heidelberg. doi: 10.1007/164_2024_720

Roles of β-adrenoceptor subtypes and therapeutics in human cardiovascular disease: heart failure, tachyarrhythmias and other cardiovascular disorders

2023

Journal Article

ST elevation myocardial infarction complicated by cardiogenic shock: Systematic review of survival predictors

Khoo, John King, Trewin, Benjamin P., Adji, Audrey, Wong, Yee Weng and Hungerford, Sara (2023). ST elevation myocardial infarction complicated by cardiogenic shock: Systematic review of survival predictors. American Journal of Medicine Open, 10 100057, 1-8. doi: 10.1016/j.ajmo.2023.100057

ST elevation myocardial infarction complicated by cardiogenic shock: Systematic review of survival predictors

2023

Journal Article

Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial

Harrington, Josephine, Mentz, Robert J., Rockhold, Frank W., Garg, Jyotsna, Butler, Javed, De Pasquale, Carmine G., Ezekowitz, Justin A., Lewis, Gregory D., O'Meara, Eileen, Ponikowski, Piotr, Troughton, Richard W., Wong, Yee Weng, Adamczyk, Robert, Blackman, Nicole and Hernandez, Adrian F. (2023). Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial. American Heart Journal, 266, 25-31. doi: 10.1016/j.ahj.2023.08.005

Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial

2023

Journal Article

Ferric Carboxymaltose in Heart Failure with Iron Deficiency

Mentz, Robert J, Garg, Jyotsna, Rockhold, Frank W, Butler, Javed, De Pasquale, Carmine G, Ezekowitz, Justin A, Lewis, Gregory D, O'Meara, Eileen, Ponikowski, Piotr, Troughton, Richard W, Wong, Yee Weng, She, Lilin, Harrington, Josephine, Adamczyk, Robert, Blackman, Nicole, Hernandez, Adrian F and for the HEART-FID Investigators (2023). Ferric Carboxymaltose in Heart Failure with Iron Deficiency. The New England Journal of Medicine, 389 (11), 975-986. doi: 10.1056/NEJMoa2304968

Ferric Carboxymaltose in Heart Failure with Iron Deficiency

2023

Journal Article

Ultrasound Enhancing Agents with Transthoracic Echocardiography for Maximal Wall Thickness in Hypertrophic Cardiomyopathy

Bois, John P., Ayoub, Chadi, Geske, Jeffrey B., Wong, Yee Weng, Abbasi, Muhannad A., Foley, Thomas A., Mulvagh, Sharon L., Scott, Christopher G., Ommen, Steve R. and Pellikka, Patricia A. (2023). Ultrasound Enhancing Agents with Transthoracic Echocardiography for Maximal Wall Thickness in Hypertrophic Cardiomyopathy. Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 7 (4), 309-319. doi: 10.1016/j.mayocpiqo.2023.06.002

Ultrasound Enhancing Agents with Transthoracic Echocardiography for Maximal Wall Thickness in Hypertrophic Cardiomyopathy

2023

Conference Publication

Clinical Trial Investigator and Patient Gender Concordance: Participation Bias?

Wattchow, N., Chan, A., Amerena, J., Atherton, J., Cross, D., Dwyer, N., Kumarasinghe, G., Lam, K., McKenzie, S., Stokes, M., Sverdlov, A., Wong, Y. and De Pasquale, C. (2023). Clinical Trial Investigator and Patient Gender Concordance: Participation Bias?. 71st Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Adelaide, SA Australia, 3-6 August 2023. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2023.06.056

Clinical Trial Investigator and Patient Gender Concordance: Participation Bias?

2022

Journal Article

Prognostic Value of Left and right ventricular deformation strain analysis on Acute Cellular rejection in Heart Transplant recipients: A 6-year outcome study

Chamberlain, Robert, Edwards, Natalie F. A., Doyle, Samantha N., Wong, Yee Weng, Scalia, Gregory M., Sabapathy, Surendran and Chan, Jonathan (2022). Prognostic Value of Left and right ventricular deformation strain analysis on Acute Cellular rejection in Heart Transplant recipients: A 6-year outcome study. International Journal of Cardiovascular Imaging, 38 (11), 2271-2281. doi: 10.1007/s10554-022-02586-z

Prognostic Value of Left and right ventricular deformation strain analysis on Acute Cellular rejection in Heart Transplant recipients: A 6-year outcome study

2022

Conference Publication

Embedding Genetic Counselling Into Cardiology Clinics: Case Studies From a Queensland Cardiology Genomics Service

Rutstein, A., Baldini, M., Morris, N., Atherton, J., McCormack, L., Wong, Y., Dashwood, A., Wee, Y., McKenzie, S., Wang, W., Hill, J., Denman, R., Ng, K. and Haqqani, H. (2022). Embedding Genetic Counselling Into Cardiology Clinics: Case Studies From a Queensland Cardiology Genomics Service. International Clinical Cardiovascular Genetics Meeting, Brisbane, QLD Australia, 12-13 May 2022. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2022.04.039

Embedding Genetic Counselling Into Cardiology Clinics: Case Studies From a Queensland Cardiology Genomics Service

2022

Conference Publication

Antiarrhythmic Effects of Phenytoin, a Novel Heart Failure Diastolic Ryanodine Channel Inhibitor, in Human Failing Ventricle

Spratt, M., Dashwood, A., Cheesman, E., Haqqani, H., Wong, Y., Chan, W., Laver, D. and Molenaar, P. (2022). Antiarrhythmic Effects of Phenytoin, a Novel Heart Failure Diastolic Ryanodine Channel Inhibitor, in Human Failing Ventricle. 70th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Gold Coast, QLD Australia, 11-14 August 2022. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2022.06.062

Antiarrhythmic Effects of Phenytoin, a Novel Heart Failure Diastolic Ryanodine Channel Inhibitor, in Human Failing Ventricle

2021

Journal Article

Who ‘nose’, is it the angiotensin receptor neprilysin inhibitor?: a case series of persistent nasal pruritus in heart failure patients receiving sacubitril/valsartan

Gan, Jaclyn, Rheault, Haunnah and Wong, Yee Weng (2021). Who ‘nose’, is it the angiotensin receptor neprilysin inhibitor?: a case series of persistent nasal pruritus in heart failure patients receiving sacubitril/valsartan. European Heart Journal - Case Reports, 5 (12) ytab506, ytab506. doi: 10.1093/ehjcr/ytab506

Who ‘nose’, is it the angiotensin receptor neprilysin inhibitor?: a case series of persistent nasal pruritus in heart failure patients receiving sacubitril/valsartan

2021

Journal Article

Randomized placebo-controlled trial of ferric carboxymaltose in heart failure with iron deficiency: rationale and design

Mentz, Robert J., Ambrosy, Andrew P., Ezekowitz, Justin A., Lewis, Gregory D., Butler, Javed, Wong, Yee Weng, De Pasquale, Carmine G., Troughton, Richard W., O’Meara, Eileen, Rockhold, Frank W., Garg, Jyostna, Samsky, Marc D., Leloudis, Dianne, Dugan, Michael, Mundy, Linda M., Hernandez, Adrian F. and on behalf of the HEART-FID Trial Investigators (2021). Randomized placebo-controlled trial of ferric carboxymaltose in heart failure with iron deficiency: rationale and design. Circulation: Heart Failure, 14 (5) e008100, 596-603. doi: 10.1161/circheartfailure.120.008100

Randomized placebo-controlled trial of ferric carboxymaltose in heart failure with iron deficiency: rationale and design

2021

Journal Article

Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (−)‐noradrenaline

Dashwood, Alexander, Cheesman, Elizabeth, Wong, Yee Weng, Haqqani, Haris, Beard, Nicole, Hay, Karen, Spratt, Melanie, Chan, Wandy and Molenaar, Peter (2021). Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (−)‐noradrenaline. Pharmacology Research and Perspectives, 9 (3) e00760, e00760. doi: 10.1002/prp2.760

Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (−)‐noradrenaline

2021

Conference Publication

High Pre-Donation Vasoactive Inotropic Score (VIS) May Be Associated with Increased Risk of Primary Graft Dysfunction in Cardiac Transplantation

Challa, A., Maddicks-Law, J., Mulligan, A., Prabhu, A. and Wong, Y. (2021). High Pre-Donation Vasoactive Inotropic Score (VIS) May Be Associated with Increased Risk of Primary Graft Dysfunction in Cardiac Transplantation. ISHLT2021 41st Annual Meeting & Scientific Sessions, Online, 24-28 April 2021. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.healun.2021.01.653

High Pre-Donation Vasoactive Inotropic Score (VIS) May Be Associated with Increased Risk of Primary Graft Dysfunction in Cardiac Transplantation

2021

Journal Article

Hypophosphatemia is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failure with reduced ejection fraction

Dashwood, Alexander, Vale, Cassandra, Laher, Shaaheen, Chui, Fiona, Hay, Karen and Wong, Yee Weng (2021). Hypophosphatemia is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failure with reduced ejection fraction. Journal of Clinical Pharmacology, 61 (4), 515-521. doi: 10.1002/jcph.1754

Hypophosphatemia is common after intravenous ferric carboxymaltose infusion among patients with symptomatic heart failure with reduced ejection fraction

2021

Conference Publication

Real World Experience with Transmedics Organ Care System in Cardiac Transplantation with Donor Organs Associated with Marginal Risk Factors

Wong, Y., Maddicks-Law, J., Raymond, P., Davidson, M., Thomson, B., Sharma, V., Javorsky, G. and Prabhu, A. (2021). Real World Experience with Transmedics Organ Care System in Cardiac Transplantation with Donor Organs Associated with Marginal Risk Factors. ISHLT2021 41st Annual Meeting & Scientific Sessions, Online, 24-28 April 2021. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.healun.2021.01.569

Real World Experience with Transmedics Organ Care System in Cardiac Transplantation with Donor Organs Associated with Marginal Risk Factors

Funding

Past funding

  • 2021 - 2023
    Anti-arrhythmic medicines: a new prototype targeting the ryanodine channel (RyR2) to reduce sudden death in heart failure patients
    Prince Charles Hospital Foundation
    Open grant
  • 2019 - 2024
    New Medicines to Keep Heart Failure Patients Alive
    Prince Charles Hospital Foundation
    Open grant

Supervision

Availability

Dr Yee Weng Wong is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Understanding How Phosphorylative and Oxidative Stress Regulate Cardiac Ryanodine Receptor-Type 2 Gating Activity to Produce an Arrhythmogenic Phenotype in Advanced Heart Failure

    Associate Advisor

    Other advisors: Honorary Professor Peter Molenaar

  • Doctor Philosophy

    Cause and prevention of stress induced arrhythmias in human heart

    Associate Advisor

    Other advisors: Honorary Professor Peter Molenaar

Media

Enquiries

Contact Dr Yee Weng Wong directly for media enquiries about:

  • AI in healthcare
  • clinical trials
  • Healthcare system improvement
  • heart failure

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au